Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$3.28 - $6.42 $38,015 - $74,407
-11,590 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$5.16 - $7.14 $14,122 - $19,542
-2,737 Reduced 19.1%
11,590 $72,000
Q4 2021

Feb 08, 2022

BUY
$6.37 - $8.18 $91,262 - $117,194
14,327 New
14,327 $101,000
Q2 2021

Aug 13, 2021

SELL
$5.44 - $8.4 $55,645 - $85,923
-10,229 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$3.91 - $6.99 $39,995 - $71,500
10,229 New
10,229 $56,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.